HIV VACCINE PRODUCTION

Information

• Research Project
• 6132718

• ApplicationId

  6132718

• Core Project Number

  N01AI095371

• Full Project Number

  N01AI095371-000

• Serial Number

  95371

• FOA Number

• Sub Project Id

• Project Start Date

  7/7/1999 - 25 years ago

• Project End Date

  7/6/2006 - 18 years ago

• Program Officer Name

• Budget Start Date

  7/7/1999 - 25 years ago

• Budget End Date

  7/6/2000 - 24 years ago

• Fiscal Year

  1999

• Support Year

• Suffix

• Award Notice Date

  -

Organizations

• THERION BIOLOGICS CORPORATION

The objective of this contract is to produce, scale-up, characterize and formulate reagent grade (GLP) and /or clinical grade (cGMP) HIV-1vector-based vaccine products for animal and/or human trials. For clinical grade materials the manufacturer must perform all required vaccine lot characterization tests. The contractor must also work together with other contractors performing safety and immunogenicity testing of the vaccine product or producing FDA-required documentation in support of an IND.

IC Name

• Activity

  N01

• Administering IC

  AI

• Application Type

  1

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

• Sub Project Total Cost

• ARRA Funded

• CFDA Code

  856

• Ed Inst. Type

• Funding ICs

• Funding Mechanism

• Study Section

• Study Section Name

• Organization Name

  THERION BIOLOGICS CORPORATION

• Organization Department

• Organization DUNS

• Organization City

  CAMBRIDGE

• Organization State

  MA

• Organization Country

  UNITED STATES

• Organization Zip Code

  02142

• Organization District

  UNITED STATES